Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Sars-CoV-2 Infections and Covid-19 Fatality

Estimation of Infection Fatality Ratio and Current Prevalence

Datos Bibliográficos

ID15463563
AutoresMarco Pota (0000-0001-6825-6393, Institute for High Performance Computing and Networking, autor de correspondencia), Andrea Pota (UOC Nefrologia e Dialisi Ospedale del Mare, 80147 Napoli, Italy), Maria Luisa Sirico (UOC Nefrologia e Dialisi Ospedale del Mare, 80147 Napoli, Italy), Massimo Esposito (0000-0002-7196-7994, Institute for High Performance Computing and Networking)
Año2020
Volumen17
Número24
Páginas9290-9290
Fecha de publicación2020-12-11
Open AccessSí
TipoARTICLE
RevistaInternational Journal of Environmental Research and Public Health (JOURNAL)
Identificadores de la revistaISSN: 1661-7827 • E-ISSN: 1660-4601
EditorialMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/ijerph17249290
PMID33322572
OpenAlexW3111006708
IdiomaEN
Referencias citadas31

COVID-19 is one of the most important problems for public health, according to the number of deaths associated to this pathology reported so far. However, from the epidemiological point of view, the dimension of the problem is still unknown, since the number of actual cases of SARS-CoV-2 infected people is underestimated, due to limited testing. This paper aims at estimating the actual Infection Fatality Ratio (number of deaths with respect to the number of infected people) and the actual current prevalence (number of infected people with respect to the entire population), both in a specific population and all over the world. With this aim, this paper proposes a method to estimate Infection Fatality Ratio of a still ongoing infection, based on a daily estimation, and on the relationship between this estimation and the number of tests performed per death. The method has been applied using data about COVID-19 from Italy. Results show a fatality ratio of about 0.9%, which is lower than previous findings. The number of actual infected people in Italy is also estimated, and results show that (i) infection started at the end of January 2020; (ii) a maximum number of about 100,000 new cases in one day was reached at the beginning of March 2020; (iii) the estimated cumulative number of infections at the beginning of October 2020 is about 4.2 million cases in Italy (more than 120 million worldwide, if a generalization is conjectured as reasonable). Therefore, the prevalence at the beginning of October 2020 is estimated at about 6.9% in Italy (1.6% worldwide, if a generalization is conjectured)

Case fatality rate · Coronavirus disease 2019 (COVID-19 · Disease · Environmental health · Estimation · Generalization · Infectious disease (medical specialty · Pandemic · Pathology · Population · Public health · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 · COVID-19 Clinical Research Studies · COVID-19 epidemiological studies · Demography · Mathematics · Medicine · SARS-CoV-2 and COVID-19 Research · Epidemiology · Internal Medicine

  • The Incubation Period of Coronavirus Disease 2019 (Covid-19) From Publicly Reported Confirmed Cases

    Stephen A Lauer, Kyra H Grantz et al.•Annals of Internal Medicine•2020

  • Hospitalization and Mortality among Black Patients and White Patients with Covid-19

    Eboni G Price-Haywood, Jeffrey Burton et al.•New England Journal of Medicine•2020

  • A novel coronavirus outbreak of global health concern

    Open Access•Chen Wang, Peter Horby et al.•The Lancet•2020

  • Coronavirus Infections—More Than Just the Common Cold

    Catharine I Paules, Hilary D Marston et al.•JAMA•2020

  • Coronavirus disease 2019 (Covid-19)

    Open Access•Harapan Harapan, Naoya Itoh et al.•Journal of Infection and Public…•2020

  • Presumed Asymptomatic Carrier Transmission of Covid-19

    Yan Bai, Lingsheng Yao et al.•JAMA•2020

  • A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission

    Open Access•Jasper Fuk-Woo Chan, Jasper Fuk‐Woo Chan et al.•The Lancet•2020

  • Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

    Dawei Wang, Bo Hu et al.•JAMA•2020

  • First Case of 2019 Novel Coronavirus in the United States

    Michelle L Holshue, Michelle Holshue et al.•New England Journal of Medicine•2020

  • Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China

    Open Access•Nanshan Chen, Min Zhou et al.•The Lancet•2020

  • Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

    Open Access•Qun Li, Xuhua Guan et al.•New England Journal of Medicine•2020

  • Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

    Open Access•Chaolin Huang, Yeming Wang et al.•The Lancet•2020

  • Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China

    Open Access•Fei Zhou, Ting Yu et al.•The Lancet•2020

Altamente citadoNo

Herramientas

Abrir DOIOpen Access
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae